LIVE LECTURE
Anaesthesia of Dogs & Cats with Cardiac Disease
- July 24, 2024 | 12:00 AEST
- Add to calendar
Starts in
Days
Hours
Minutes
About the webinar
The sedation or anaesthesia of patients with cardiac disease often poses a challenge to veterinarians. Patients with cardiovascular dysfunction, have a significantly higher risk of morbidity and mortality following anaesthesia or sedation due to decreased physiological reserves and inability to adequately compensate for alterations in heart rate, preload, afterload, and cardiac output. Additionally, there is a greater chance of decompensation if these animals are exposed to sudden stressful conditions or increased metabolic demand (e.g., anxiety, surgery, pain). A reduced cardiovascular reserve may also predispose to a greater risk of fluid-overload when intravenous fluids are used to compensate for the vasodilating effects of anaesthetic agents, further adding to the complexity associated with the management of these cases. This session presents strategies for the sedation and anaesthetic management of patients with specific cardiovascular diseases commonly seen in veterinary practice.
You will be able to join the live webinar directly from this page.
When is it?
Australia and New Zealand
USA and Canada
Other Countries
Australia and New Zealand
Date:Â Wednesday, 24 July 2024
Time:Â 12:00 AESTÂ [Sydney]Â | 14:00 NZSTÂ [Auckland]
Time:Â 12:00 AESTÂ [Sydney]Â | 14:00 NZSTÂ [Auckland]
USA and Canada
Date:Â Tuesday, 23 July 2024
Time:Â 22:00 EDT
Time:Â 22:00 EDT
Other Countries
All Countries are Invited to Join this Webinar! To check the time in your zone/country, please click here.
Note: This webinar is being recorded. If you are unable to attend the live lecture, a link to the recording will be shared with you a few days following the lecture.
Speaker
Dr Leon Warne
BSc(Biol), BBiomedSc(Hons1), BSc, BVMS, MVS, MANZCVS (Anaesthesia), DACVAA, PhD
Founder | Clinical Director
The Vet Pharmacist
Leon graduated as a Doctor of Veterinary Medicine from Murdoch University (Western Australia) in 2009.
Following graduation he undertook an internship in anaesthesia, emergency and critical care medicine.
Leon joined the Melbourne Veterinary School’s anaesthesia and analgesia section at the University of Melbourne in 2010 where he completed a specialty training program in anaesthesia and pain management, a clinical master degree in anaesthesia as well as a PhD in pain-management and assessment.
In 2015 he completed an externship in paediatric anaesthesia and trauma management at The Austin and Royal Melbourne Hospitals. Leon is a Diplomate of the American College of Veterinary Anesthesia and Analgesia, a Member of the Australian and New Zealand College of Veterinary Scientists anaesthesia chapter and an Australasian Veterinary Boards Council registered specialist in anaesthesia. Leon is a director of Veterinary Anaesthesia and Pain Management Australia and an adjunct senior lecturer at Murdoch University.
His clinical research interests are assessment and management of pain in patients’ incapable of self-reporting; intravenous fluid therapy; and utilisation of novel drug delivery technologies to optimise bioavailability and dosing efficacy of medicinal cannabis therapeutics.
Leon joined the Melbourne Veterinary School’s anaesthesia and analgesia section at the University of Melbourne in 2010 where he completed a specialty training program in anaesthesia and pain management, a clinical master degree in anaesthesia as well as a PhD in pain-management and assessment.
In 2015 he completed an externship in paediatric anaesthesia and trauma management at The Austin and Royal Melbourne Hospitals. Leon is a Diplomate of the American College of Veterinary Anesthesia and Analgesia, a Member of the Australian and New Zealand College of Veterinary Scientists anaesthesia chapter and an Australasian Veterinary Boards Council registered specialist in anaesthesia. Leon is a director of Veterinary Anaesthesia and Pain Management Australia and an adjunct senior lecturer at Murdoch University.
His clinical research interests are assessment and management of pain in patients’ incapable of self-reporting; intravenous fluid therapy; and utilisation of novel drug delivery technologies to optimise bioavailability and dosing efficacy of medicinal cannabis therapeutics.
Live Webinars
This webinar starts at 12:00 AEST
on July 24, 2024.
1 Structured CE Credit
Race Approval Pending
